Ricinoleic acid

CAS No. 141-22-0

Ricinoleic acid( —— )

Catalog No. M21328 CAS No. 141-22-0

Ricinoleic acid is a natural product that constitutes about 90% of the fatty acids in castor oil.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ricinoleic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Ricinoleic acid is a natural product that constitutes about 90% of the fatty acids in castor oil.
  • Description
    Ricinoleic acid is a natural product that constitutes about 90% of the fatty acids in castor oil.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    141-22-0
  • Formula Weight
    298.5
  • Molecular Formula
    C18H34O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:20mg/ml(67mM)
  • SMILES
    CCCCCC[C@H](C/C=C\CCCCCCCC(O)=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Alves S P Araujo C M Queiroga R C et al. New insights on the metabolism of ricinoleic acid in ruminants[J]. Journal of dairy ence 2017 100(10):8018-8032.
molnova catalog
related products
  • (Ile8)-Oxytocin

    (Ile8)-Oxytocin

  • Mastoparan X

    Mastoparan X is a GTP-binding regulatory protein (G protein)-activating peptide, and a tetradecapeptide from wasp venom. Mastoparan X acts function by the direct activation of G protein that couple to phospholipase C to cause secretion from various kinds of cells.

  • Difopein TFA

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.